Featured

The pharmaceutical industry is currently facing a critical challenge in the management of safety risks associated with new drug candidates. For decades, the high rate of attrition during late-stage clinical trials has been a primary driver of the rising...

The development of a new pharmaceutical manufacturing site has traditionally been a multi-year undertaking, involving a complex sequence of design, construction, and rigorous validation. For companies operating in the fast-moving cell and gene therapy sector, this traditional timeline is...

Color consistency is critical in pharmaceutical quality control (QC). Variations in tablet coatings, powders, liquids and packaging materials can indicate formulation inconsistencies, contamination risks or manufacturing deviations. To improve accuracy and reduce subjective visual inspection, pharmaceutical manufacturers increasingly rely...

A blister pack may seem like a simple enough concept until you’re trying to prove that it will open cleanly every time. Peel testing turns each peel into data so you can protect dose integrity, support and child resistance...

Exploration of the chemical, physical, and environmental factors that compromise the integrity of modern therapeutics, and the advanced testing protocols used to ensure safety.

The evolution of pharmaceutical manufacturing is driven largely by the rising demands facing the industry. Inflation, strict regulations and a greater demand for quality control and supply chain visibility are notable here. Additionally, as medical therapies advance, there is...

Randomised controlled trials (RCTs) have long been the gold standard of clinical trials, with the most robust evidence of safety and effectiveness of new medicines. But the traditional RCT model—characterised by strict protocols, predetermined sample sizes, and rigid timelines—is...